Scientific Spotlights

EADV Congress 2025 Press Release
New research presented at the EADV Congress 2025 reveals that people with psoriasis face a significantly increased risk of developing age-related macular degeneration (AMD), a leading cause of vision loss.

EADV Congress 2025 Press Release
Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss medications, new research has shown.

EADV Congress 2025 Press Release
A new international study presented at the EADV Congress 2025 reveals that adults with atopic eczema are significantly more likely to experience suicidal thoughts, with researchers uncovering the key factors driving this elevated risk.

Bullous Diseases: Diagnosis, Challenges & Advances
Join us for an insightful exploration into the world of bullous skin diseases, featuring expert-led presentations and real-world clinical insights.
Why to attend this session:
Enhance diagnostic accuracy, learn about rare and complex cases, get updated on the latest therapeutic approaches, network with fellow dermatologists and experts

Recent advances in psoriasis treatment focus on personalized approaches, emphasizing early and aggressive intervention with IL-17/IL-23 inhibitors and novel small molecules to achieve long-term remission, though treatment resistance remains a clinical challenge.

Holistic care, including proactive management of cardiometabolic comorbidities and patient-centered treatment choices, is crucial for optimizing outcomes and reducing systemic inflammation’s long-term impact.

Hair and nail dermoscopy highlights the diagnostic value of dermoscopy in identifying inflammatory nail diseases like psoriasis and lichen planus, which show distinct patterns such as pitting, onycholysis, or dorsal pterygium and may require biopsy for confirmation. Dermoscopy is also essential in diagnosing non-melanoma skin cancers like BCC and SCC, as well as rarer malignancies such as adnexal carcinomas and cutaneous lymphomas, by revealing specific vascular and structural features that guide treatment decisions.

This session explores two challenging types of alopecia: androgenetic alopecia (AGA) and neutrophilic scarring alopecias, including dissecting cellulitis (DC) and folliculitis decalvans (FD). Experts will review the latest in diagnosis, pathophysiology, and personalized treatment strategies, ranging from established therapies to emerging options across pediatric and adult patients.

In this presentation, we explore how skin microbiome dysbiosis contributes to acne and hidradenitis suppurativa (HS). Acne involves C. acnes phylotype IA1 dominance and S. epidermidis imbalance, while HS is linked to biofilm-related inflammation. We also highlight emerging microbiome-based therapies and personalized skincare approaches.

This presentation reviews topical, intralesional, systemic, biologic and small molecules treatments, outlining indications based on the site and severity of nail involvement.